<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Med</journal-id><journal-id journal-id-type="iso-abbrev">J Clin Med</journal-id><journal-id journal-id-type="pmc-domain-id">2745</journal-id><journal-id journal-id-type="pmc-domain">jclinmed</journal-id><journal-id journal-id-type="publisher-id">jcm</journal-id><journal-title-group><journal-title>Journal of Clinical Medicine</journal-title></journal-title-group><issn pub-type="epub">2077-0383</issn><publisher><publisher-name>Multidisciplinary Digital Publishing Institute  (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11312855</article-id><article-id pub-id-type="pmcid-ver">PMC11312855.1</article-id><article-id pub-id-type="pmcaid">11312855</article-id><article-id pub-id-type="pmcaiid">11312855</article-id><article-id pub-id-type="pmid">39124590</article-id><article-id pub-id-type="doi">10.3390/jcm13154323</article-id><article-id pub-id-type="publisher-id">jcm-13-04323</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Five-Year Retrospective Study from a Single Center on the Location, Presentation, Diagnosis, and Management of 110 Patients with Aneurysms of the Femoral and Popliteal Arteries of the Lower Limb</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0006-5154-2901</contrib-id><name name-style="western"><surname>Serafin</surname><given-names initials="M">Micha&#322;</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#8211; original draft</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="c1-jcm-13-04323" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>&#321;yko-Morawska</surname><given-names initials="D">Dorota</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Szostek</surname><given-names initials="J">Julia</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="https://credit.niso.org/contributor-roles/validation/">Validation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sta&#324;czyk</surname><given-names initials="D">Dariusz</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#8211; review &amp; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>M&#261;ka</surname><given-names initials="M">Magdalena</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kania</surname><given-names initials="I">Iga</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kuczmik</surname><given-names initials="W">Wac&#322;aw</given-names></name></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name name-style="western"><surname>Isoda</surname><given-names initials="K">Kikuo</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-jcm-13-04323">Department of General Surgery, Vascular Surgery, Angiology and Phlebology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 14 Medyk&#243;w Street, 45-47 Zio&#322;owa Street, 40-635 Katowice, Poland; <email>dorota.lyko@gmail.com</email> (D.&#321;.-M.); <email>s81394@365.sum.edu.pl</email> (J.S.); <email>darekstanczyk@interia.pl</email> (D.S.); <email>s81151@365.sum.edu.pl</email> (M.M.); <email>s80989@365.sum.edu.pl</email> (I.K.); <email>wkuczmik@interia.pl</email> (W.K.)</aff><author-notes><corresp id="c1-jcm-13-04323"><label>*</label>Correspondence: <email>michal.j.serafin@gmail.com</email>; Tel.: +48-728-742-782</corresp></author-notes><pub-date pub-type="epub"><day>24</day><month>7</month><year>2024</year></pub-date><pub-date pub-type="collection"><month>8</month><year>2024</year></pub-date><volume>13</volume><issue>15</issue><issue-id pub-id-type="pmc-issue-id">468562</issue-id><elocation-id>4323</elocation-id><history><date date-type="received"><day>20</day><month>6</month><year>2024</year></date><date date-type="rev-recd"><day>16</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>24</day><month>07</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>10</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-28 19:25:38.793"><day>28</day><month>08</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 by the authors.</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="jcm-13-04323.pdf"/><abstract><p><bold>Background:</bold> Peripheral aneurysms, although known about for centuries, are challenging to monitor due to their asymptomatic nature. Advanced imaging has improved detection, which is crucial for preventing emergent complications. This five-year retrospective study from a single center aimed to evaluate the location, presentation, diagnosis, and management of 110 patients with aneurysms of the femoral and popliteal arteries of the lower limb. <bold>Materials and methods:</bold> The study included 71 true aneurysms and 39 pseudoaneurysms patients treated between 2018&#8211;2023. Treatment methods were based on aneurysm size, atherosclerosis severity, and operation risk. The study assessed patient demographics, surgical details, postoperative complications, and aneurysm characteristics. <bold>Results:</bold> Acute limb ischemia was more prevalent in true aneurysms (25.4% vs. 7.7%; <italic toggle="yes">p</italic> = 0.02). Aneurysmectomy was performed more frequently in pseudoaneurysms (87.2% vs. 54.9%; <italic toggle="yes">p</italic> &lt; 0.001), while endovascular treatment and surgical bypass were more common in true aneurysms (Endovascular: 22.5% vs. 2.6%; <italic toggle="yes">p</italic> = 0.01; bypass: 21.1% vs. 0%; <italic toggle="yes">p</italic> &lt; 0.001). Early postoperative complications occurred in 22.7% of patients. The 12-month freedom from reoperations (73.7% vs. 87%; <italic toggle="yes">p</italic> = 0.07), amputations (97.7% vs. 93.8%; <italic toggle="yes">p</italic> = 0.2), and graft stenosis (78.7% vs. 86.87%; <italic toggle="yes">p</italic> = 0.06) showed no significant differences between groups. <bold>Conclusions:</bold> Lower limb aneurysms often present with non-specific symptoms, leading to late diagnosis and life-threatening complications. Both open and endovascular treatments are feasible, though more research is needed for pseudoaneurysms. Vigilant follow-up is crucial due to potential adverse events, though overall mortality and morbidity remain low.</p></abstract><kwd-group><kwd>lower limb</kwd><kwd>aneurysm</kwd><kwd>pseudoaneurysm</kwd><kwd>endovascular procedure</kwd><kwd>surgery</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-jcm-13-04323"><title>1. Introduction</title><p>The first peripheral artery aneurysm (PA) was described over 4000 years ago in the Ebers Papyrus (ca. 2000 BC) [<xref rid="B1-jcm-13-04323" ref-type="bibr">1</xref>]. Today, its incidence is difficult to define due to its asymptomatic nature. However, improved imaging techniques and better healthcare availability have increased detectability [<xref rid="B2-jcm-13-04323" ref-type="bibr">2</xref>]. The two-thirds of all PAs are lower limb aneurysms [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>]. PAs are classified into true aneurysms, a vessel dilatation involving all arterial wall layers, and pseudoaneurysms, defined as a dilation caused by a hematoma contained only by the tunica adventitia or a pseudo-fibrous capsule [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>]. The incidence varies depending on the location and type of aneurysm.</p><p>The etiology of lower limb true aneurysms, as well as general true aneurysms, is unknown. Molecular studies suggest that a combination of genetic defects and inflammatory processes is responsible [<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>,<xref rid="B6-jcm-13-04323" ref-type="bibr">6</xref>]. Pseudoaneurysms are related to traumatic injury of the vessel wall, leading to blood entering the surrounding tissue and forming a pulsatile hematoma [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B7-jcm-13-04323" ref-type="bibr">7</xref>].</p><p>In up to 40% of cases, lower limb aneurysms are clinically silent [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>]. Symptoms can be easily overlooked [<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>,<xref rid="B8-jcm-13-04323" ref-type="bibr">8</xref>]. The most common symptoms include lower limb pain and a palpable mass, while up to 77% of symptomatic patients may present life-threatening complications such as chronic thrombosis with intermittent claudication, acute limb ischemia due to acute thrombosis, and aneurysm rupture [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B8-jcm-13-04323" ref-type="bibr">8</xref>,<xref rid="B9-jcm-13-04323" ref-type="bibr">9</xref>].</p><p>Duplex ultrasonography (USG) should be the preferred method for screening and detecting femoral and popliteal aneurysms [<xref rid="B10-jcm-13-04323" ref-type="bibr">10</xref>]. Computed tomography angiography (CTA) is the most effective diagnostic method for evaluating lower limb aneurysms before surgical intervention [<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>,<xref rid="B7-jcm-13-04323" ref-type="bibr">7</xref>].</p><p>Interventions are primarily indicated for symptomatic lower limb aneurysms. Current guidelines recommend repairing asymptomatic popliteal artery aneurysms (PAAs) &#8805;20 mm in diameter to mitigate the risk of thromboembolic events and limb loss. For patients at higher clinical risk, repair may be delayed until the aneurysm reaches &#8805;30 mm. For PAAs &lt;20 mm, repair should be considered if there is a thrombus, clinical suspicion of embolism, or poor distal runoff on imaging. Open PAA repair is advised for asymptomatic patients with a life expectancy of at least 5 years and an adequate saphenous vein. For those with reduced life expectancy, endovascular repair should be considered [<xref rid="B11-jcm-13-04323" ref-type="bibr">11</xref>]. Symptomatic common femoral artery aneurysms or asymptomatic ones over 2.5 cm warrant surgical intervention [<xref rid="B12-jcm-13-04323" ref-type="bibr">12</xref>]. Treatment options include minimally invasive methods like ultrasound-guided compression or thrombin injection, and classical surgical procedures [<xref rid="B13-jcm-13-04323" ref-type="bibr">13</xref>]. Endovascular treatment is also increasingly used for lower limb aneurysms [<xref rid="B13-jcm-13-04323" ref-type="bibr">13</xref>]. Given the mobility of the lower limb, stent grafts that are flexible and resistant to kinking should be used [<xref rid="B12-jcm-13-04323" ref-type="bibr">12</xref>,<xref rid="B14-jcm-13-04323" ref-type="bibr">14</xref>,<xref rid="B15-jcm-13-04323" ref-type="bibr">15</xref>].</p><p>Given the diversity of lower limb aneurysms and their treatment options, appropriate treatment should be tailored to each case, considering the aneurysm&#8217;s etiology, location, and diameter, as well as the patient&#8217;s clinical status and postoperative quality of life [<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>,<xref rid="B8-jcm-13-04323" ref-type="bibr">8</xref>].</p><p>The primary objective of this study is to clinically characterize lower limb aneurysms and analyze the perioperative, short-term, and long-term outcomes of surgical treatment based on data from the Department of General Surgery, Vascular Surgery, Angiology, and Phlebology at the Medical University of Silesia in Katowice, Poland. This five-year retrospective study evaluates the location, presentation, diagnosis, and management of 110 patients with lower limb artery aneurysms.</p></sec><sec id="sec2-jcm-13-04323"><title>2. Materials and Methods</title><sec id="sec2dot1-jcm-13-04323"><title>2.1. Study Design and Population</title><p>The retrospective study included all patients from the Department of General Surgery, Vascular Surgery, Angiology, and Phlebology at the Medical University of Silesia in Katowice, Poland, who were treated with open or endovascular methods for a femoral (common, deep, superficial) or popliteal artery aneurysm from January 2018 to December 2023. We individually reviewed the medical records from the electronic system for all treatments of lower limb aneurysms and analyzed only those with primary open or endovascular procedures. Patients who received interventions for recurrent aneurysms were excluded from further analysis.</p><p>The study group consisted of 110 adult patients (95, 86.4% men; 15, 13.6% women), aged 15&#8211;98 years old (67.5 IQR 10) and was divided into two subgroups according to the type of aneurysm: true aneurysm (n = 71; 64.5%) and pseudoaneurysm (n = 39; 35.5%; <xref rid="jcm-13-04323-f001" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec2dot2-jcm-13-04323"><title>2.2. Diagnostic Criteria</title><p>True aneurysms were diagnosed using computed tomography angiography (CTA), following the 2022 clinical practice guidelines from the Society for Vascular Surgery on popliteal aneurysms and the guidelines for the Management of Patients with Peripheral Arterial Disease. The diagnostic criteria for true aneurysms included a focal, isolated dilation of the vessel exceeding 1.5 times the diameter of the normal, healthy segment of the artery, with the aneurysm wall encompassing all three layers of the arterial wall: intima, media, and adventitia [<xref rid="B11-jcm-13-04323" ref-type="bibr">11</xref>,<xref rid="B16-jcm-13-04323" ref-type="bibr">16</xref>]. An example angiographic image showing the characteristic dilation of the vessel with all three arterial wall layers involved can be seen in <xref rid="jcm-13-04323-f002" ref-type="fig">Figure 2</xref>a.</p><p>Pseudoaneurysms were diagnosed using CTA, in accordance with the European Society for Vascular Surgery clinical practice guidelines from 2011, updated in 2019. The diagnostic criteria for pseudoaneurysms included a dilation or outpouching of the artery, consisting of one or two layers of the vessel wall, contained only by periarterial connective tissue [<xref rid="B17-jcm-13-04323" ref-type="bibr">17</xref>,<xref rid="B18-jcm-13-04323" ref-type="bibr">18</xref>]. An example CTA image showing the outpouching of the artery surrounded by periarterial connective tissue defining the boundary is provided in <xref rid="jcm-13-04323-f002" ref-type="fig">Figure 2</xref>b.</p><p>The patients with lower limb aneurysm were considered for invasive treatment in case of the symptomatic aneurysm/pseudoaneurysm or in case of asymptomatic common femoral artery aneurysm/pseudoaneurysm that exceeded 25 mm or asymptomatic popliteal artery aneurysm/pseudoaneurysm exceeding 20 mm [<xref rid="B11-jcm-13-04323" ref-type="bibr">11</xref>,<xref rid="B16-jcm-13-04323" ref-type="bibr">16</xref>,<xref rid="B17-jcm-13-04323" ref-type="bibr">17</xref>,<xref rid="B18-jcm-13-04323" ref-type="bibr">18</xref>].</p></sec><sec id="sec2dot3-jcm-13-04323"><title>2.3. Methods of Treatment</title><p>All patients before surgical treatment were evaluated by a multispecialist team of vascular surgeons and radiologists who treated the patients and determined their qualification for a specific procedure based on CTA.</p><p>The inclusion criteria for aneurysmectomy/surgical bypass/endovascular treatment/Aneurysmectomy with surgical bypass are detailed below.</p><p>Aneurysmectomy was performed in cases of aneurysm/pseudoaneurysm with mild atherosclerosis of the artery before and after the aneurysm sac, accompanied by good blood flow. This procedure was considered when the vessel exhibited limited atherosclerotic changes, ensuring that the integrity of the artery could be maintained and optimal blood flow could be preserved.</p><p>Surgical bypass was performed in cases of aneurysm with severe atherosclerosis of the artery before and after the aneurysm sac, accompanied by reduced blood flow. This procedure was chosen when the arterial segments adjacent to the aneurysm were significantly affected by atherosclerotic plaque, compromising blood circulation. The procedure aimed to reroute blood flow around the obstructed sections and aneurysm sac, restoring adequate perfusion to the lower limb and preventing the growth of the aneurysm.</p><p>Aneurysmectomy with surgical bypass was performed in cases of aneurysm compression of the vein and/or nerve or anastomotic pseudoaneurysms with severe atherosclerosis of the artery before and after the aneurysm sac, accompanied by reduced blood flow. This combined approach was necessary when the aneurysm or pseudoaneurysm was sizable, and the surrounding arterial segments were heavily affected by atherosclerotic changes, leading to compromised blood circulation. Additionally, symptomatic nerve or vein compression mandated surgical repair with aneurysm resection. This intervention was critical to relieve pressure on the affected nerves or veins and restore normal function.</p><p>In addition, according to clinical practice guidelines [<xref rid="B11-jcm-13-04323" ref-type="bibr">11</xref>], during open procedures, patients with acute limb ischemia underwent simultaneous surgical thrombectomy. In cases of chronic occlusive disease, patients underwent simultaneous endarterectomy. This approach allowed us to minimize the radiation exposure received by the patient while simultaneously restoring proper circulation to the lower limb.</p><p>Endovascular treatment was performed in high-risk patients with contraindications for open surgical treatment. This minimally invasive procedure was chosen for individuals who were deemed unsuitable for traditional open surgery due to factors such as advanced age, comorbidities, or other medical conditions that increased the risk of surgical complications. Endovascular treatment allowed for effective management of the aneurysm while minimizing the overall risk to the patient.</p><p>In addition, according to clinical practice guidelines [<xref rid="B11-jcm-13-04323" ref-type="bibr">11</xref>], during the endovascular procedures, patients with acute limb ischemia underwent simultaneous mechanical thrombectomy, while in the case of chronic occlusive disease, patients underwent simultaneous percutaneous angioplasty with/without stenting. This approach allowed us to quickly restore proper circulation to the lower limb.</p><p>During aneurysmectomy and surgical bypass, the SilverGraf (B. Braun Melsungen AG, Berlin, Germany) or Gelsoft&#8482; Plus Vascular Prosthesis (Terumo Aortic, Inchinnan, UK) was used. The type of vascular prosthesis was chosen by the main vascular surgeon performing the procedure.</p><p>The GORE VIABAHN VBX Balloon Expandable Endoprosthesis (W. L. Gore &amp; Associates, Flagstaff, AZ, USA) was used in endovascular treatment.</p></sec><sec id="sec2dot4-jcm-13-04323"><title>2.4. Definitions</title><p>Early postoperative complications were defined as the occurrence of complications during a patient&#8217;s hospitalization or during 30 days after the surgical procedure.</p><p>Early reoperation was defined as the performance of additional procedures due to the occurrence of early postoperative complications during a patient&#8217;s hospitalization or during 30 days after the surgical procedure.</p><p>Late postoperative complications were defined as the occurrence of complications &gt;30 days after the surgical procedure.</p><p>Late reoperation was defined as the performance of additional procedures due to the occurrence of late postoperative complications &gt;30 days after the surgical procedure.</p><p>The total duration of hospitalization was defined from the day of admission to the day of discharge from the hospital. Meanwhile, the duration of postoperative hospitalization was defined as the interval between the day of surgery and the day of discharge.</p><p>Follow-up was defined as the patient&#8217;s last registered visit to the ward or clinic.</p><p>Overall survival (OS) was measured from the date of the surgical procedure to either the date of death or the date of the last contact in the ward or clinic.</p><p>Graft stenosis was delineated as a constriction of the graft surpassing 75% and manifested by a &gt;3.5-fold increase in peak systolic velocity, as ascertained via duplex ultrasound or angiographic evaluation.</p><p>Amputations were defined as a major below-knee, above-knee, or femoral amputation.</p><p>Reintervention was warranted for grafts demonstrating symptomatic stenosis and for asymptomatic grafts deemed at risk, defined as those exhibiting a peak systolic velocity ratio &gt;3.5 to 4 or displaying low graft velocities &lt;30 cm/s.</p><p>Reoperation-amputation-stenosis (RAS events) was defined as a variable denoted by the occurrence of reoperation, amputation, or graft stenosis at any time after the primary procedure.</p></sec><sec id="sec2dot5-jcm-13-04323"><title>2.5. Analyzed Data</title><p>Parameters such as patients&#8217; general characteristics (i.e., age, gender, comorbidities, clinical symptoms), the type and the duration of surgery, incidence of postoperative complications, reoperations, mortality, duration of hospitalization as well as the aneurysm localization, diameter, and follow-up were analyzed in the study.</p><p>The patients&#8217; general characteristics (i.e., age, gender, comorbidities, clinical symptoms), as well as details about the incidence of postoperative complications (including graft stenosis) and reoperations, were obtained from the patient&#8217;s medical history from our department.</p><p>Details about the localization of the aneurysms, as well as the duration and type of the procedure, were collected from the description of the patient&#8217;s surgery.</p><p>Aneurysm diameter was obtained from each patient&#8217;s CTA.</p><p>Follow-up data such as late complications (including graft stenosis), late reoperations, and mortality were obtained from the patient&#8217;s medical history from the surgical clinic and/or from the department.</p></sec><sec id="sec2dot6-jcm-13-04323"><title>2.6. Statistical Analysis</title><p>The statistical analysis was performed using Statistica<sup>&#174;</sup> (Tulsa, OK, USA, 2013) software version 13.3 (StatSoft). Absolute values and percentages were used to present qualitative variables. Ranges, means, and standard deviations or medians with interquartile ranges were applied for quantitative variables. The Shapiro&#8211;Wilk test was used to determine statistical distribution in the analyzed patients. Between-group comparisons were performed for two types of aneurysm (true aneurysm and pseudoaneurysm) in terms of demographics, peri- and postoperative parameters, as well as follow-up parameters. Analysis was performed using the chi-square test, Fisher&#8217;s exact test, or the Mann&#8211;Whitney U test. The predictive factors of early postoperative complications were calculated using univariate logistic regression analysis. Overall survival analysis, freedom from reoperations, amputations, graft stenosis, and RAS events were performed using the Kaplan&#8211;Meier estimator. The log-rank test was used to compare the overall survival analysis, freedom from reoperations, amputations, graft stenosis, and RAS events between the true aneurysm and pseudoaneurysm groups. The analysis of prognostic factors for the overall survival analysis, freedom from reoperations, amputations, graft stenosis, and RAS events was performed using the univariate Cox proportional hazards regression model and included the patient&#8217;s age, gender, presence of arterial hypertension, generalized atherosclerosis, coronary artery disease, history of myocardial infarction, as well as the aneurysm size, localization, type of the procedure and vascular graft material. The variables identified as significant by univariate analysis were selected for multivariate analysis with the Cox proportional hazards regression model to identify the independent predictors. A <italic toggle="yes">p</italic>-value &lt; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-jcm-13-04323"><title>3. Results</title><sec id="sec3dot1-jcm-13-04323"><title>3.1. Patient Demographics and Descriptive Data</title><p>There was no statistically significant difference between patients with true aneurysms and pseudoaneurysms in terms of age. More males were treated for true aneurysm compared to pseudoaneurysm (65 (91.6%) vs. 30 (76.9%); <italic toggle="yes">p</italic> = 0.03).</p><p>In the whole group, 90 (81.8%) patients had comorbidities. The most common comorbidity was arterial hypertension, noted in 77 (70%) patients, followed by generalized atherosclerosis (n = 43; 39.1%) and coronary artery disease (n = 29; 26.4%). More patients with pseudoaneurysm had generalized atherosclerosis compared to the true aneurysm group (23 (59%) vs. 20 (28.2%); <italic toggle="yes">p</italic> = 0.002). For the remaining comorbidities and the overall presence of comorbidities, there were no statistically significant differences. History of cigarette smoking was reported by 52 (47.3%) of patients, while 38 (34.5%) patients were currently smoking cigarettes with no significant differences between groups (<italic toggle="yes">p</italic> = 0.8; <italic toggle="yes">p</italic> = 0.5, respectively)</p><p>On admission, 71 (64.5%) patients were presenting clinical symptoms. The most common was lower limb pain noted in 43 (39.1%) patients, followed by acute limb ischemia (n = 21; 9.1%) and intermittent claudication (n = 17; 15.5%). Acute limb ischemia was reported more often in the true aneurysm group compared to the pseudoaneurysm group (18 (25.4%) vs. 3 (7.7%); <italic toggle="yes">p</italic> = 0.02). For the remaining clinical symptoms and the overall presence of clinical symptoms, no statistically significant differences were observed.</p><p>Fifty-seven (51.8%) patients were diagnosed with other aneurysms (in addition to the treated one), with the most common being the abdominal aorta aneurysm (n = 21; 19.1%). Patients with true aneurysms more often had other aneurysms than patients in the pseudoaneurysm group (42 (59.2%) vs. 15 (38.5%); <italic toggle="yes">p</italic> = 0.04). There was no statistically significant difference between groups in terms of other aneurysm localizations (<xref rid="jcm-13-04323-t001" ref-type="table">Table 1</xref>).</p></sec><sec id="sec3dot2-jcm-13-04323"><title>3.2. Characteristics of Aneurysms in the Study Population</title><p>The most common etiology of pseudoaneurysm was anastomotic pseudoaneurysm (n = 37; 94.9%). Meanwhile, most true aneurysms had idiopathic etiology (51; 46.4%). The popliteal artery was the most common localization of aneurysms (n = 54; 49.1%), followed by the common femoral artery (n = 53; 48.2%), superficial femoral artery (n = 2; 1.8%), and deep femoral artery (n = 1; 0.9%). In the patients with true aneurysms, significantly more often, the aneurysm was located in the popliteal artery compared to the pseudoaneurysm group (52 (73.2%) vs. 2 (5.1%); <italic toggle="yes">p</italic> &lt; 0.001), while the common femoral artery was more often the localization of the pseudoaneurysm compared to the true aneurysm (36 (92.3%) vs. 17 (23.9%); <italic toggle="yes">p</italic> &lt; 0.001). This finding can be associated with the fact that most of the pseudoaneurysm in our group was a complication of femoral anastomosis (n = 36; 92.3%). Median aneurysm size was 36 IQR 20 mm, with no significant difference between groups (<xref rid="jcm-13-04323-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3dot3-jcm-13-04323"><title>3.3. Procedural Characteristics and Outcomes in Patients Undergoing Aneurysm Repair</title><p>The median duration of the procedure was 165.5 (45&#8211;365) IQR 77.5 min. In 103 (93.7%) patients, intraoperative blood loss was &lt;400 mL. Intraoperative transfusion of red blood cells (RBC) was needed in 6 (5.5%) patients, while intraoperative transfusion of fresh frozen plasma was needed in 2 (1.8%) patients. There was no statistically significant difference in the duration of the procedure or intraoperative blood loss, transfusion of red blood cells (RBC), or transfusion of fresh frozen plasma (FFP) between the two groups.</p><p>The most common type of the procedure was aneurysmectomy, which was performed in 73 (66.4%) patients; it was followed by endovascular treatment (n = 17; 15.5%). Aneurysmectomy was performed more often in patients with pseudoaneurysm than with true aneurysm (34 (87.2%) vs. 39 (54.9%); <italic toggle="yes">p</italic> &lt; 0.001), while endovascular treatment and surgical bypass were performed more often in true aneurysm group compared with pseudoaneurysm group (16 (22.5%) vs. 1 (2.6%); <italic toggle="yes">p</italic> = 0.01, 15 (21.1%) vs. 0 (0%); <italic toggle="yes">p</italic> &lt; 0.001). There was no statistically significant difference in the performance of aneurysmectomy with bypass between both groups.</p><p>The median duration of hospitalization was 8 (4&#8211;100) IQR 4 days. There was no significant difference in the duration of hospitalization and duration of the hospitalization after the procedure between patients with true aneurysms and pseudoaneurysms.</p><p>Early postoperative complications occurred in 25 (22.7%) patients; the most common were as follows: surgical site infection (n = 10; 9.1%), hematoma (n = 8; 7.3%), acute limb ischemia (n = 4; 3.6%), myocardial infarction (n = 1; 0.9%), femoral abscess (n = 1; 0.9%), and C.Difficile infection (n = 1; 0.9%). Early postoperative reoperation was needed in 10 (9.1%) patients due to the hematoma (n = 5; 4.5%), acute limb ischemia (n = 4; 3.6%), and femoral abscess (n = 1; 0.9%). There was no significant difference in the overall occurrence of early postoperative complications and in the individual complications, as well as in the performance of early reoperations between both groups. In-hospital mortality was 0% (<xref rid="jcm-13-04323-t003" ref-type="table">Table 3</xref>).</p><p>In univariate logistic regression analysis, the occurrence of postoperative complications was associated only with the occurrence of generalized atherosclerosis in patients (<italic toggle="yes">p</italic> = 0.02, Odds ratio = 3, 95% confidence interval (95% CI) = 1.2&#8211;7.7). Therefore, it was the only independent predictive factor for early postoperative complications (<xref rid="jcm-13-04323-t004" ref-type="table">Table 4</xref>).</p></sec><sec id="sec3dot4-jcm-13-04323"><title>3.4. Long-Term Follow-Up and Outcomes in Patients Undergoing Aneurysm Repair</title><p>The median follow-up time was 16 (1&#8211;68) IQR 31 months. There was no statistically significant difference in follow-up time between both groups.</p><p>During the follow-up period, a total of 27 (24.5%) late postoperative complications occurred. There was no statistically significant difference between patients with true aneurysm and pseudoaneurysm in the overall occurrence of late postoperative complications and in the individual complications.</p><p>Late postoperative reoperations were needed in a total of 13 (11.8%) patients due to the acute limb ischemia (n = 9; 8.2%), prosthesis infection (n = 2; 1.8%), recurrence of pseudoaneurysm (n = 1; 0.9%), and popliteal abscess (n = 1; 0.9%). There were no significant differences between both groups in the performance of late reoperations. In addition, in five (4.5%) patients, due to acute limb ischemia, the recombinant tissue plasminogen activator (r-tPA) therapy was required.</p><p>During the follow-up period, three (2.7%) deaths occurred due to acute heart failure (n = 1; 0.9%), intracerebral hemorrhage (n = 1; 0.9%), and traffic accidents (n = 1; 0.9%). There were no significant differences between both groups in terms of mortality (<xref rid="jcm-13-04323-t005" ref-type="table">Table 5</xref>).</p></sec><sec id="sec3dot5-jcm-13-04323"><title>3.5. Reoperations</title><p>On survival analysis, the freedom from reoperations at 12 months was 78.8% standard error (SE) 4.6%. There was no statistically significant difference between the true aneurysm and pseudoaneurysm groups in terms of 12 months of freedom from reoperations (73.7% SE 6.3% vs. 87% SE 6.2%; <italic toggle="yes">p</italic> = 0.07; <xref rid="jcm-13-04323-f003" ref-type="fig">Figure 3</xref>).</p><p>In univariate Cox proportional hazards regression model analysis, there were no significant differences in freedom from reoperations between patients in terms of age, gender, history of cigarette smoking, current cigarette smoking, presence of comorbidities, aneurysm localization, aneurysm size, the type of the procedure and graft material. Therefore, the multivariate Cox proportional hazards regression model analysis was not performed (<xref rid="jcm-13-04323-t006" ref-type="table">Table 6</xref>).</p></sec><sec id="sec3dot6-jcm-13-04323"><title>3.6. Amputations</title><p>The survival analysis showed that at 12 months, the freedom from amputations after was 96.3% SE 2.1%. There was no statistically significant difference between the true aneurysm and pseudoaneurysm groups in terms of freedom from amputations after 12 months (97.7% SE 2.3% vs. 93.8% SE 4.3%; <italic toggle="yes">p</italic> = 0.2; <xref rid="jcm-13-04323-f004" ref-type="fig">Figure 4</xref>).</p><p>No significant differences in freedom from amputations were observed among patients concerning age, gender, history of cigarette smoking, current cigarette smoking, presence of comorbidities, aneurysm localization, aneurysm size, the type of procedure and graft material in the univariate Cox proportional hazards regression model analysis. As a result, multivariate Cox regression model analysis was not conducted (<xref rid="jcm-13-04323-t007" ref-type="table">Table 7</xref>).</p></sec><sec id="sec3dot7-jcm-13-04323"><title>3.7. Graft Stenosis</title><p>The survival analysis revealed that at 12 months, the freedom from graft stenosis was 81.8% (SE 4.4%). There was no statistically significant difference observed between the true aneurysm and pseudoaneurysm groups in terms of the freedom from graft stenosis after 12 months (78.7% SE 5.9% vs. 86.87% SE 6.3%; <italic toggle="yes">p</italic> = 0.06; <xref rid="jcm-13-04323-f005" ref-type="fig">Figure 5</xref>).</p><p>The univariate Cox proportional hazards regression model analysis showed that localization of the aneurysm at the popliteal artery (hazard ratio (HR) = 5.1; 95% CI = 1.8&#8211;14.5; <italic toggle="yes">p</italic> = 0.002) and at the common femoral artery (HR = 0.1; 95% CI = 0.04&#8211;0.5; <italic toggle="yes">p</italic> = 0.001), as well as the performance of aneurysmectomy (HR = 0.3; 95% CI = 0.1&#8211;0.8; <italic toggle="yes">p</italic> = 0.01) and surgical bypass (HR = 3.8; 95%CI = 1.4&#8211;10.2; <italic toggle="yes">p</italic> = 0.001), were predictive factors for graft stenosis. However, in the multivariate analysis, none of the above variables proved to be an independent predictor factor (<xref rid="jcm-13-04323-t008" ref-type="table">Table 8</xref>).</p></sec><sec id="sec3dot8-jcm-13-04323"><title>3.8. RAS Events</title><p>The survival analysis demonstrated that at 12 months, the freedom from RAS events was 73.3% (SE 5%). There was no statistically significant difference observed between the true aneurysm and pseudoaneurysm groups regarding the freedom from RAS events after 12 months (66.7% SE 6.8% vs. 83.9% SE 6.8%; <italic toggle="yes">p</italic> = 0.06; <xref rid="jcm-13-04323-f006" ref-type="fig">Figure 6</xref>).</p><p>The univariate Cox proportional hazards regression model analysis showed that localization of the aneurysm at the popliteal artery (HR= 2; 95% CI = 1&#8211;4.3; <italic toggle="yes">p</italic> = 0.04) and at the common femoral artery (HR = 0.4; 95% CI= 0.2&#8211;0.9; <italic toggle="yes">p</italic> = 0.002), as well as aneurysm size (HR= 0.3; 95% CI = 0.1&#8211;0.8; <italic toggle="yes">p</italic> = 0.01), were predictive factors for RAS events. However, multivariate analysis showed that only the localization of the aneurysm at the common femoral artery (HR = 0.1; 95% CI = 0.02&#8211;0.5; <italic toggle="yes">p</italic> = 0.005) and aneurysm size (HR = 1.1; 95% CI 1&#8211;1.1; <italic toggle="yes">p</italic> = 0.01) were the independent predictive factors for RAS events (<xref rid="jcm-13-04323-t009" ref-type="table">Table 9</xref>).</p></sec><sec id="sec3dot9-jcm-13-04323"><title>3.9. Overall Survival (OS)</title><p>Finally, the survival analysis demonstrated that at 12 months, OS was 98.2% SE 1%. There was no statistically significant difference observed between the true aneurysm and pseudoaneurysm groups regarding the OS after 12 months (98.2% SE 1.8% vs. 100%; <italic toggle="yes">p</italic> = 0.3; <xref rid="jcm-13-04323-f007" ref-type="fig">Figure 7</xref>).</p><p>The univariate Cox proportional hazards regression model analysis showed that only the patient&#8217;s age was a positive predictive factor for mortality (HR = 1.2; 95% CI 1&#8211;1.3; <italic toggle="yes">p</italic> = 0.01; <xref rid="jcm-13-04323-t010" ref-type="table">Table 10</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-jcm-13-04323"><title>4. Discussion</title><p>The study examined demographics, clinical presentations, procedural outcomes, and long-term follow-up of lower limb aneurysm patients. Although age did not differ significantly between true aneurysms and pseudoaneurysms groups, males predominated in the true aneurysms group (91.6% vs. 76.9%, <italic toggle="yes">p</italic> = 0.03). Symptoms included lower limb pain (39.1%), acute limb ischemia (19.1%), and intermittent claudication (15.5%). Acute limb ischemia was more frequent in the true aneurysms group compared to pseudoaneurysm one (25.4% vs. 7.7%, <italic toggle="yes">p</italic> = 0.02). Coexisting aneurysms, notably abdominal aorta aneurysms, occurred in 51.8%, with a higher incidence in the true aneurysms group (59.2% vs. 38.5%, <italic toggle="yes">p</italic> = 0.04). Most aneurysms were located in the popliteal artery (49.1%) or the common femoral artery (48.2%), with pseudoaneurysms mainly due to anastomotic complications in the common femoral artery (92.3%). Aneurysmectomy was the most common procedure (66.4%), especially in the pseudoaneurysms group (87.2%), while endovascular repair predominated in true aneurysms (22.5%). Hospitalization duration and early complications were similar between groups. Long-term outcomes, including complications, reoperations, and mortality, were comparable. Survival analysis indicated comparable outcomes in terms of freedom from reoperations, amputations, graft stenosis, RAS events, and overall survival, with age being the sole predictive factor for mortality.</p><p>Lower limb aneurysm epidemiology underscores the male predominance, with true aneurysms occurring nearly twice as often in men compared to women (3% vs. 1.6%) [<xref rid="B19-jcm-13-04323" ref-type="bibr">19</xref>]. Sokhal et al. [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>] suggest that the female gender may predispose to pseudoaneurysm formation. In our study, more males were treated for true aneurysms compared to pseudoaneurysms (65 (91.6%) vs. 30 (76.9%); <italic toggle="yes">p</italic> = 0.03), whereas more females were treated for pseudoaneurysms than true aneurysms (9 (23.1%) vs. 6 (8.5%); <italic toggle="yes">p</italic> = 0.03). This gender disparity likely arises from multiple factors. Men are frequently exposed to risk factors such as smoking, alcohol use, hypertension, and physical inactivity, which increase the likelihood of developing true arterial aneurysms [<xref rid="B20-jcm-13-04323" ref-type="bibr">20</xref>]. Occupational hazards and environmental exposures, common among men in physically demanding or industrial jobs, further contribute to this disparity [<xref rid="B21-jcm-13-04323" ref-type="bibr">21</xref>]. Genetic factors also play a role, as familial clustering and specific genetic variations are associated with increased aneurysm risk [<xref rid="B22-jcm-13-04323" ref-type="bibr">22</xref>]. Understanding these multifaceted influences&#8212;behavioral, hormonal, environmental, and genetic&#8212;is crucial for tailoring preventive strategies and personalized treatments for individuals at risk of developing aneurysms [<xref rid="B20-jcm-13-04323" ref-type="bibr">20</xref>,<xref rid="B21-jcm-13-04323" ref-type="bibr">21</xref>,<xref rid="B22-jcm-13-04323" ref-type="bibr">22</xref>].</p><p>The incidence of lower limb aneurysms may be underestimated due to a high proportion of clinically silent cases, with the incidence between 30&#8211;40% [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B23-jcm-13-04323" ref-type="bibr">23</xref>]. Our study similarly found 39 (35.5%) patients without symptoms. In symptomatic cases, serious complications occurred in 30&#8211;77% of patients, including acute limb ischemia and aneurysm rupture [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>,<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>,<xref rid="B8-jcm-13-04323" ref-type="bibr">8</xref>]. In our group, 47 (66.2%) patients experienced such complications. Acute limb ischemia was more frequent in the true aneurysms group than pseudoaneurysms group (18 (25.4%) vs. 3 (7.7%); <italic toggle="yes">p</italic> = 0.02), possibly linked to pseudoaneurysms primarily arising from arterial anastomosis (37 (94.9%)) Therefore, the patients in this group were on dual antiplatelet therapy, which reduces the risk of acute thrombosis.</p><p>Patients with lower limb aneurysms require thorough imaging to detect coexisting aortic, contra-, and ipsilateral aneurysms. Coexisting aneurysm rates range widely (27% to 92%) [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>,<xref rid="B24-jcm-13-04323" ref-type="bibr">24</xref>]. In our study, 57 (51.8%) patients had additional aneurysms, predominantly abdominal aortic aneurysms (AAAs; 21; 19.1%) [<xref rid="B3-jcm-13-04323" ref-type="bibr">3</xref>,<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>,<xref rid="B24-jcm-13-04323" ref-type="bibr">24</xref>]. Comprehensive vascular imaging, including bedside ultrasound and Doppler ultrasound, is crucial. Constantino et al. [<xref rid="B25-jcm-13-04323" ref-type="bibr">25</xref>] demonstrated 94% to 99% sensitivity of these modalities for AAA [<xref rid="B25-jcm-13-04323" ref-type="bibr">25</xref>], and Diwan et al. [<xref rid="B2-jcm-13-04323" ref-type="bibr">2</xref>] highlighted the superior sensitivity of the Doppler ultrasound in detecting PAs compared to physical examination [<xref rid="B2-jcm-13-04323" ref-type="bibr">2</xref>]. Thus, Doppler ultrasound should be integrated into routine examinations of patients diagnosed with lower limb aneurysms.</p><p>Lower limb aneurysms most commonly occur in the popliteal artery and common femoral artery due to their location at the limb&#8217;s most mobile joints, which subjects them to unique biomechanical stresses that can weaken arterial walls. The common femoral artery, increasingly used for endovascular procedures, may also be weakened iatrogenically [<xref rid="B13-jcm-13-04323" ref-type="bibr">13</xref>]. In our study, the most frequent sites were the popliteal artery (53; 49.1%) and the common femoral artery (52; 48.2%). Pseudoaneurysms predominantly affect the common femoral artery, often associated with catheterization or arterial anastomosis, whereas true aneurysms are more prevalent in the popliteal artery and are often linked with atherosclerosis [<xref rid="B4-jcm-13-04323" ref-type="bibr">4</xref>,<xref rid="B5-jcm-13-04323" ref-type="bibr">5</xref>,<xref rid="B13-jcm-13-04323" ref-type="bibr">13</xref>,<xref rid="B26-jcm-13-04323" ref-type="bibr">26</xref>]. Similarly, in our study, pseudoaneurysms were significantly more common in the common femoral artery compared to true aneurysms (36 (92.3% vs. 17 (23.9%); <italic toggle="yes">p</italic> &lt; 0.001), while true aneurysms were more often located in the popliteal artery compared to pseudoaneurysms (52; 73.2% vs. 2; 5.1%; <italic toggle="yes">p</italic> &lt; 0.001).</p><p>Surgical management of lower limb aneurysms varies based on etiology, type, and location. Current evidence suggests that pseudoaneurysms resulting from arterial anastomosis are best treated with aneurysmectomy with graft interposition/bypass [<xref rid="B27-jcm-13-04323" ref-type="bibr">27</xref>,<xref rid="B28-jcm-13-04323" ref-type="bibr">28</xref>,<xref rid="B29-jcm-13-04323" ref-type="bibr">29</xref>]. In the study by Markowi&#263; et al. [<xref rid="B28-jcm-13-04323" ref-type="bibr">28</xref>], 81.6% of patients underwent these procedures, compared to 97.4% in our cohort. The difference possibly occurred due to the absence of infected pseudoaneurysms in our group. Despite advancements in endovascular techniques, their use in lower limb pseudoaneurysms remains limited. Pogorzelski et al. [<xref rid="B29-jcm-13-04323" ref-type="bibr">29</xref>] reported only 3.5% of cases treated with endovascular methods, consistent with our finding of 1 (2.6%) patient treated with endovascular methods. Further research is needed to establish the efficacy of endovascular repair in lower limb pseudoaneurysms.</p><p>On the other hand, in the treatment of true aneurysms, both open surgical procedures (aneurysmectomy or bypass) and endovascular methods are widely employed. However, recent studies indicate no significant differences in in-hospital mortality, rates of lower extremity amputation, or readmission rates between endovascular methods and open surgery [<xref rid="B30-jcm-13-04323" ref-type="bibr">30</xref>,<xref rid="B31-jcm-13-04323" ref-type="bibr">31</xref>]. Gali&#241;anes et al. [<xref rid="B30-jcm-13-04323" ref-type="bibr">30</xref>] treated 18.5% of patients with endovascular repair and 81.5% with open surgical procedures for true lower limb aneurysms; similarly, in our study, 16 (22.5%) patients underwent endovascular treatment while 55 (77.5%) underwent open surgical procedures.</p><p>Early postoperative complications were observed in 25 (22.7%) patients, in a similar number in patients with true aneurysm (16; 22.5%) and pseudoaneurysm (9; 23.1%), with 0% mortality in the whole group. The findings are consistent with the previously published data regarding the management of lower limb aneurysms. In the literature, the postoperative morbidity rate in patients with true aneurysm is 10.2&#8211;30%, while mortality is 0&#8211;5% [<xref rid="B30-jcm-13-04323" ref-type="bibr">30</xref>,<xref rid="B31-jcm-13-04323" ref-type="bibr">31</xref>,<xref rid="B32-jcm-13-04323" ref-type="bibr">32</xref>]. In the surgical treatment of pseudoaneurysm, morbidity rates range from 21% to 27.6%, while mortality is 0&#8211;9.2% [<xref rid="B28-jcm-13-04323" ref-type="bibr">28</xref>,<xref rid="B29-jcm-13-04323" ref-type="bibr">29</xref>]. The only independent predictive factor for early complications was the occurrence of generalized atherosclerosis (OR = 3, 95% CI = 1.2&#8211;7.7, <italic toggle="yes">p</italic> = 0.02). This may be attributed to the fact that generalized atherosclerosis impairs the blood supply to the regions served by the affected artery and additionally elevates the risk of acute thrombosis or infection [<xref rid="B33-jcm-13-04323" ref-type="bibr">33</xref>]. In our study, 15 (21.1%) early postoperative complications (10 (9.1%)&#8212;Surgical site infection, 4 (3.6%)&#8212;Acute limb ischemia, and 1 (0.9%) Myocardial infarction) can be associated with impaired blood supply and/or acute thrombosis and therefore with the occurrence of generalized atherosclerosis.</p><sec><title>Limitations of the Study</title><p>The study is primarily constrained by its retrospective design, focusing on a specifically chosen subset of patients from a single medical institution. Moreover, the underrepresentation of females within the study cohort raises concerns regarding the generalizability of findings to the broader female demographic. Additionally, the impact of the COVID-19 pandemic on healthcare access likely led to delayed diagnoses between 2020 and 2022, potentially affecting the presentation of symptomatic aneurysms. Further limitations stem from the inherent biases associated with retrospective analyses. The reliance on available medical records may have introduced selection bias, influencing patient inclusion criteria. Additionally, the study&#8217;s single-center approach limits the extrapolation of results to diverse patient populations and healthcare settings, where institutional practices and patient demographics may differ. Finally, the retrospective nature of the study precludes the establishment of causal relationships between variables, while residual confounding factors may have confounded observed associations.</p></sec></sec><sec sec-type="conclusions" id="sec5-jcm-13-04323"><title>5. Conclusions</title><p>Symptoms associated with lower limb aneurysms often lack specificity, making their diagnosis challenging and potentially resulting in delayed identification and management. Consequently, patients may present with severe complications endangering life or limb. Predominantly, true aneurysms manifest in the popliteal artery, while pseudoaneurysms, particularly those arising from arterial anastomoses, are typically observed in the common femoral artery. Treatment modalities for lower limb aneurysms include both traditional open surgical approaches and endovascular techniques; nonetheless, the latter warrants further investigation, particularly concerning pseudoaneurysms. Notably, the presence of generalized atherosclerosis may serve as a predictive indicator for the development of early postoperative complications. Given the potential for adverse events, diligent postoperative surveillance is imperative for patients undergoing surgical intervention for lower limb aneurysms. However, it is reassuring that overall rates of postoperative mortality and morbidity remain relatively low.</p></sec></body><back><ack><title>Acknowledgments</title><p>We would like to express our sincere gratitude to Maja Cesarz for their invaluable assistance with the language editing of this manuscript.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#8217;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, M.S., D.&#321;.-M., J.S., M.M. and I.K.; methodology, M.S., D.&#321;.-M. and J.S.; software, M.S.; validation, M.S., D.&#321;.-M. and J.S.; formal analysis, M.S.; investigation, J.S., M.M. and I.K.; resources, W.K.; writing&#8212;original draft preparation, M.S.; writing&#8212;review and editing, D.&#321;.-M., D.S. and W.K.; visualization, M.S.; supervision, D.&#321;.-M., D.S. and W.K.; project administration, D.S. and W.K.; All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The ethical principles outlined in the 1964 Declaration of Helsinki on Medical Research Involving Human Subjects were adhered to, and all of the procedures were performed in accordance with the Helsinki Declaration. Our retrospective study was classified as exempt (identification number BNW/NWN/0052/KB/54/24, 4 March 2024) from the Institutional Review Board (IRB) of the Medical University of Silesia in Katowice approval based on the Polish Act of 5 December 1996, on the Profession of Medical Doctors and Doctors of Dental Medicine (Journal of Laws of 2023, item 1516 as amended). According to this legislation, retrospective data analysis of medical records is not considered a medical experiment and does not require evaluation by IRB.</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The raw data supporting the conclusions of this article will be made available by the authors on request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-jcm-13-04323"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Galland</surname><given-names>R.B.</given-names></name></person-group><article-title>History of the management of popliteal artery aneurysms</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2008</year><volume>35</volume><fpage>466</fpage><lpage>472</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2007.11.011</pub-id><pub-id pub-id-type="pmid">18180184</pub-id></element-citation></ref><ref id="B2-jcm-13-04323"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Diwan</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sarkar</surname><given-names>R.</given-names></name><name name-style="western"><surname>Stanley</surname><given-names>J.C.</given-names></name><name name-style="western"><surname>Zelenock</surname><given-names>G.B.</given-names></name><name name-style="western"><surname>Wakefield</surname><given-names>T.W.</given-names></name></person-group><article-title>Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms</article-title><source>J. Vasc. Surg.</source><year>2000</year><volume>31</volume><fpage>863</fpage><lpage>869</lpage><pub-id pub-id-type="doi">10.1067/mva.2000.105955</pub-id><pub-id pub-id-type="pmid">10805875</pub-id></element-citation></ref><ref id="B3-jcm-13-04323"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sokhal</surname><given-names>B.S.</given-names></name><name name-style="western"><surname>Ma</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Rajagopalan</surname><given-names>S.</given-names></name></person-group><article-title>Femoral artery aneurysms</article-title><source>Br. J. Hosp. Med.</source><year>2022</year><volume>83</volume><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.12968/hmed.2022.0258</pub-id><pub-id pub-id-type="pmid">36594777</pub-id></element-citation></ref><ref id="B4-jcm-13-04323"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rowlands</surname><given-names>C.</given-names></name><name name-style="western"><surname>Youssef</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rajagopalan</surname><given-names>S.</given-names></name></person-group><article-title>Popliteal arterial aneurysms</article-title><source>Br. J. Hosp. Med.</source><year>2022</year><volume>83</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.12968/hmed.2021.0572</pub-id><pub-id pub-id-type="pmid">35653317</pub-id></element-citation></ref><ref id="B5-jcm-13-04323"><label>5.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kassem</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Oropallo</surname><given-names>A.</given-names></name><name name-style="western"><surname>Gonzalez</surname><given-names>L.</given-names></name></person-group><article-title>Popliteal Artery Aneurysm</article-title><source>StatPearls [Internet]</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2024</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK430863/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK430863/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-02-16">(accessed on 16 February 2024)</date-in-citation><pub-id pub-id-type="pmid">28613613</pub-id></element-citation></ref><ref id="B6-jcm-13-04323"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fioranelli</surname><given-names>A.</given-names></name><name name-style="western"><surname>Carpentieri</surname><given-names>E.A.</given-names></name><name name-style="western"><surname>Wolosker</surname><given-names>N.</given-names></name><name name-style="western"><surname>Castelli</surname><given-names>V.</given-names><suffix>Jr.</suffix></name><name name-style="western"><surname>Caffaro</surname><given-names>R.A.</given-names></name></person-group><article-title>Rupture of Thrombosed Popliteal Aneurysm: A Case Report</article-title><source>Ann. Vasc. Surg.</source><year>2018</year><volume>51</volume><fpage>324.e7</fpage><lpage>324.e10</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2017.12.024</pub-id><pub-id pub-id-type="pmid">29518513</pub-id></element-citation></ref><ref id="B7-jcm-13-04323"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stone</surname><given-names>P.A.</given-names></name><name name-style="western"><surname>Campbell</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>AbuRahma</surname><given-names>A.F.</given-names></name></person-group><article-title>Femoral pseudoaneurysms after percutaneous access</article-title><source>J. Vasc. Surg.</source><year>2014</year><volume>60</volume><fpage>1359</fpage><lpage>1366</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2014.07.035</pub-id><pub-id pub-id-type="pmid">25175631</pub-id></element-citation></ref><ref id="B8-jcm-13-04323"><label>8.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Saleem</surname><given-names>T.</given-names></name><name name-style="western"><surname>D&#8217;Cruz</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Baril</surname><given-names>D.T.</given-names></name></person-group><article-title>Femoral Aneurysm Repair</article-title><source>StatPearls [Internet]</source><publisher-name>StatPearls Publishing</publisher-name><publisher-loc>Treasure Island, FL, USA</publisher-loc><year>2024</year><comment>Available online: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK470329/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK470329/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2023-07-14">(accessed on 14 July 2023)</date-in-citation><pub-id pub-id-type="pmid">29262227</pub-id></element-citation></ref><ref id="B9-jcm-13-04323"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wright</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Matchett</surname><given-names>W.J.</given-names></name><name name-style="western"><surname>Cruz</surname><given-names>C.P.</given-names></name><name name-style="western"><surname>James</surname><given-names>C.A.</given-names></name><name name-style="western"><surname>Culp</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Eidt</surname><given-names>J.F.</given-names></name><name name-style="western"><surname>McCowan</surname><given-names>T.C.</given-names></name></person-group><article-title>Popliteal artery disease: Diagnosis and treatment</article-title><source>Radiographics</source><year>2004</year><volume>24</volume><fpage>467</fpage><lpage>479</lpage><pub-id pub-id-type="doi">10.1148/rg.242035117</pub-id><pub-id pub-id-type="pmid">15026594</pub-id></element-citation></ref><ref id="B10-jcm-13-04323"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golchehr</surname><given-names>B.</given-names></name><name name-style="western"><surname>Zeebregts</surname><given-names>C.J.</given-names></name><name name-style="western"><surname>Reijnen</surname><given-names>M.M.P.J.</given-names></name><name name-style="western"><surname>Tielliu</surname><given-names>I.F.J.</given-names></name></person-group><article-title>Long-term outcome of endovascular popliteal artery aneurysm repair</article-title><source>J. Vasc. Surg.</source><year>2018</year><volume>67</volume><fpage>1797</fpage><lpage>1804</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2017.09.040</pub-id><pub-id pub-id-type="pmid">29291906</pub-id></element-citation></ref><ref id="B11-jcm-13-04323"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Farber</surname><given-names>A.</given-names></name><name name-style="western"><surname>Angle</surname><given-names>N.</given-names></name><name name-style="western"><surname>Avgerinos</surname><given-names>E.</given-names></name><name name-style="western"><surname>Dubois</surname><given-names>L.</given-names></name><name name-style="western"><surname>Eslami</surname><given-names>M.</given-names></name><name name-style="western"><surname>Geraghty</surname><given-names>P.</given-names></name><name name-style="western"><surname>Haurani</surname><given-names>M.</given-names></name><name name-style="western"><surname>Jim</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ketteler</surname><given-names>E.</given-names></name><name name-style="western"><surname>Pulli</surname><given-names>R.</given-names></name><etal/></person-group><article-title>The Society for Vascular Surgery clinical practice guidelines on popliteal artery aneurysms</article-title><source>J. Vasc. Surg.</source><year>2022</year><volume>75</volume><fpage>109S</fpage><lpage>120S</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2021.04.040</pub-id><pub-id pub-id-type="pmid">34023430</pub-id></element-citation></ref><ref id="B12-jcm-13-04323"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lawrence</surname><given-names>P.F.</given-names></name><name name-style="western"><surname>Harlander-Locke</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Oderich</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Humphries</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Landry</surname><given-names>G.J.</given-names></name><name name-style="western"><surname>Ballard</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Abularrage</surname><given-names>C.J.</given-names></name></person-group><article-title>The current management of isolated degenerative femoral artery aneurysms is too aggressive for their natural history</article-title><source>J. Vasc. Surg.</source><year>2014</year><volume>59</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2013.08.090</pub-id><pub-id pub-id-type="pmid">24461859</pub-id></element-citation></ref><ref id="B13-jcm-13-04323"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohan</surname><given-names>I.V.</given-names></name><name name-style="western"><surname>Stephen</surname><given-names>M.S.</given-names></name></person-group><article-title>Peripheral arterial aneurysms: Open or endovascular surgery?</article-title><source>Prog. Cardiovasc. Dis.</source><year>2013</year><volume>56</volume><fpage>36</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.pcad.2013.06.001</pub-id><pub-id pub-id-type="pmid">23993237</pub-id></element-citation></ref><ref id="B14-jcm-13-04323"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tamashiro</surname><given-names>G.A.</given-names></name><name name-style="western"><surname>Tamashiro</surname><given-names>A.</given-names></name><name name-style="western"><surname>Villegas</surname><given-names>M.O.</given-names></name><name name-style="western"><surname>Dini</surname><given-names>A.E.</given-names></name><name name-style="western"><surname>Moll&#243;n</surname><given-names>A.P.</given-names></name><name name-style="western"><surname>Zelaya</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Soledispa-Suarez</surname><given-names>C.I.</given-names></name><name name-style="western"><surname>Diaz</surname><given-names>J.A.</given-names></name></person-group><article-title>Flexions of the popliteal artery: Technical considerations of femoropopliteal stenting</article-title><source>J. Invasive Cardiol.</source><year>2011</year><volume>23</volume><fpage>431</fpage><lpage>433</lpage><pub-id pub-id-type="pmid">21972163</pub-id></element-citation></ref><ref id="B15-jcm-13-04323"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>N.G.</given-names></name><name name-style="western"><surname>Rokosh</surname><given-names>R.S.</given-names></name><name name-style="western"><surname>Garg</surname><given-names>K.</given-names></name><name name-style="western"><surname>Safran</surname><given-names>B.</given-names></name><name name-style="western"><surname>Rockman</surname><given-names>C.B.</given-names></name><name name-style="western"><surname>Maldonado</surname><given-names>T.S.</given-names></name><name name-style="western"><surname>Sadek</surname><given-names>M.</given-names></name><name name-style="western"><surname>Lamparello</surname><given-names>P.</given-names></name><name name-style="western"><surname>Jacobowitz</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Barfield</surname><given-names>M.E.</given-names></name><etal/></person-group><article-title>Endovascular treatment of popliteal artery aneurysms has comparable long-term outcomes to open repair with shorter lengths of stay</article-title><source>J. Vasc. Surg.</source><year>2021</year><volume>74</volume><fpage>1565</fpage><lpage>1572.e1</lpage><pub-id pub-id-type="doi">10.1016/j.jvs.2021.04.046</pub-id><pub-id pub-id-type="pmid">33957229</pub-id></element-citation></ref><ref id="B16-jcm-13-04323"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hirsch</surname><given-names>A.T.</given-names></name><name name-style="western"><surname>Haskal</surname><given-names>Z.J.</given-names></name><name name-style="western"><surname>Hertzer</surname><given-names>N.R.</given-names></name><name name-style="western"><surname>Bakal</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Creager</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Halperin</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Hiratzka</surname><given-names>L.F.</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>W.R.</given-names></name><name name-style="western"><surname>Olin</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Puschett</surname><given-names>J.B.</given-names></name><etal/></person-group><article-title>ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>e463</fpage><lpage>e654</lpage><pub-id pub-id-type="pmid">16549646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCULATIONAHA.106.174526</pub-id></element-citation></ref><ref id="B17-jcm-13-04323"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moll</surname><given-names>F.L.</given-names></name><name name-style="western"><surname>Powell</surname><given-names>J.T.</given-names></name><name name-style="western"><surname>Fraedrich</surname><given-names>G.</given-names></name><name name-style="western"><surname>Verzini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Haulon</surname><given-names>S.</given-names></name><name name-style="western"><surname>Waltham</surname><given-names>M.</given-names></name><name name-style="western"><surname>van Herwaarden</surname><given-names>J.A.</given-names></name><name name-style="western"><surname>Holt</surname><given-names>P.J.E.</given-names></name><name name-style="western"><surname>van Keulen</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Rantner</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Management of abdominal aortic aneurysms clinical practice guidelines of the European society for vascular surgery</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2011</year><volume>41</volume><issue>(Suppl. S1)</issue><fpage>S1</fpage><lpage>S58</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2010.09.011</pub-id><pub-id pub-id-type="pmid">21215940</pub-id></element-citation></ref><ref id="B18-jcm-13-04323"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wanhainen</surname><given-names>A.</given-names></name><name name-style="western"><surname>Verzini</surname><given-names>F.</given-names></name><name name-style="western"><surname>Van Herzeele</surname><given-names>I.</given-names></name><name name-style="western"><surname>Allaire</surname><given-names>E.</given-names></name><name name-style="western"><surname>Bown</surname><given-names>M.</given-names></name><name name-style="western"><surname>Cohnert</surname><given-names>T.</given-names></name><name name-style="western"><surname>Dick</surname><given-names>F.</given-names></name><name name-style="western"><surname>van Herwaarden</surname><given-names>J.</given-names></name><name name-style="western"><surname>Karkos</surname><given-names>C.</given-names></name><name name-style="western"><surname>Koelemay</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Editor&#8217;s Choice&#8212;European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysm</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2019</year><volume>57</volume><fpage>8</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2018.09.020</pub-id><pub-id pub-id-type="pmid">30528142</pub-id></element-citation></ref><ref id="B19-jcm-13-04323"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peeran</surname><given-names>S.</given-names></name><name name-style="western"><surname>DeMartino</surname><given-names>R.R.</given-names></name><name name-style="western"><surname>Huang</surname><given-names>Y.</given-names></name><name name-style="western"><surname>Fleming</surname><given-names>M.</given-names></name><name name-style="western"><surname>Kalra</surname><given-names>M.</given-names></name><name name-style="western"><surname>Oderich</surname><given-names>G.S.</given-names></name><name name-style="western"><surname>Duncan</surname><given-names>A.A.</given-names></name><name name-style="western"><surname>Bower</surname><given-names>T.C.</given-names></name><name name-style="western"><surname>Gloviczki</surname><given-names>P.</given-names></name></person-group><article-title>Outcomes of women treated for popliteal artery aneurysms</article-title><source>Ann. Vasc. Surg.</source><year>2016</year><volume>34</volume><fpage>187</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2015.12.010</pub-id><pub-id pub-id-type="pmid">27116904</pub-id></element-citation></ref><ref id="B20-jcm-13-04323"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kent</surname><given-names>K.C.</given-names></name></person-group><article-title>Abdominal Aortic Aneurysms</article-title><source>N. Engl. J. Med.</source><year>2014</year><volume>371</volume><fpage>2101</fpage><lpage>2108</lpage><pub-id pub-id-type="doi">10.1056/NEJMcp1401430</pub-id><pub-id pub-id-type="pmid">25427112</pub-id></element-citation></ref><ref id="B21-jcm-13-04323"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lederle</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>G.R.</given-names></name><name name-style="western"><surname>Wilson</surname><given-names>S.E.</given-names></name><name name-style="western"><surname>Chute</surname><given-names>E.P.</given-names></name><name name-style="western"><surname>Littooy</surname><given-names>F.N.</given-names></name><name name-style="western"><surname>Bandyk</surname><given-names>D.</given-names></name><name name-style="western"><surname>Krupski</surname><given-names>W.C.</given-names></name><name name-style="western"><surname>Barone</surname><given-names>G.W.</given-names></name><name name-style="western"><surname>Acher</surname><given-names>C.W.</given-names></name><name name-style="western"><surname>Ballard</surname><given-names>D.J.</given-names></name></person-group><article-title>Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Group</article-title><source>Ann. Intern. Med.</source><year>1997</year><volume>126</volume><fpage>441</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-126-6-199703150-00004</pub-id><pub-id pub-id-type="pmid">9072929</pub-id></element-citation></ref><ref id="B22-jcm-13-04323"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuivaniemi</surname><given-names>H.</given-names></name><name name-style="western"><surname>Platsoucas</surname><given-names>C.D.</given-names></name></person-group><article-title>Aortic Aneurysms: Pathogenesis and Mechanisms</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2012</year><volume>43</volume><fpage>261</fpage><lpage>267</lpage></element-citation></ref><ref id="B23-jcm-13-04323"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>H.A.</given-names></name><name name-style="western"><surname>Minc</surname><given-names>S.</given-names></name><name name-style="western"><surname>Babrowski</surname><given-names>T.</given-names></name></person-group><article-title>Peripheral artery aneurysm</article-title><source>Surg. Clin. N. Am.</source><year>2013</year><volume>93</volume><fpage>911</fpage><lpage>923</lpage><pub-id pub-id-type="doi">10.1016/j.suc.2013.04.008</pub-id><pub-id pub-id-type="pmid">23885937</pub-id></element-citation></ref><ref id="B24-jcm-13-04323"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ravn</surname><given-names>H.</given-names></name><name name-style="western"><surname>Bergqvist</surname><given-names>D.</given-names></name><name name-style="western"><surname>Bj&#246;rck</surname><given-names>M.</given-names></name><collab>Swedish Vascular Registry</collab></person-group><article-title>Nationwide study of the outcome of popliteal artery aneurysms treated surgically</article-title><source>Br. J. Surg.</source><year>2007</year><volume>94</volume><fpage>970</fpage><lpage>977</lpage><pub-id pub-id-type="doi">10.1002/bjs.5755</pub-id><pub-id pub-id-type="pmid">17520712</pub-id></element-citation></ref><ref id="B25-jcm-13-04323"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Costantino</surname><given-names>T.G.</given-names></name><name name-style="western"><surname>Bruno</surname><given-names>E.C.</given-names></name><name name-style="western"><surname>Handly</surname><given-names>N.</given-names></name><name name-style="western"><surname>Dean</surname><given-names>A.J.</given-names></name></person-group><article-title>Accuracy of emergency medicine ultrasound in the evaluation of abdominal aortic aneurysm</article-title><source>J. Emerg. Med.</source><year>2005</year><volume>29</volume><fpage>455</fpage><lpage>460</lpage><pub-id pub-id-type="doi">10.1016/j.jemermed.2005.02.016</pub-id><pub-id pub-id-type="pmid">16243207</pub-id></element-citation></ref><ref id="B26-jcm-13-04323"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gabriel</surname><given-names>M.</given-names></name><name name-style="western"><surname>Pawlaczyk</surname><given-names>K.</given-names></name><name name-style="western"><surname>Waliszewski</surname><given-names>K.</given-names></name><name name-style="western"><surname>Krasi&#324;ski</surname><given-names>Z.</given-names></name><name name-style="western"><surname>Majewski</surname><given-names>W.</given-names></name></person-group><article-title>Location of femoral artery puncture site and the risk of postcatheterization pseudoaneurysm formation</article-title><source>Int. J. Cardiol.</source><year>2007</year><volume>120</volume><fpage>167</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2006.09.018</pub-id><pub-id pub-id-type="pmid">17250906</pub-id></element-citation></ref><ref id="B27-jcm-13-04323"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Demarche</surname><given-names>M.</given-names></name><name name-style="western"><surname>Waltregny</surname><given-names>D.</given-names></name><name name-style="western"><surname>van Damme</surname><given-names>H.</given-names></name><name name-style="western"><surname>Limet</surname><given-names>R.</given-names></name></person-group><article-title>Femoral anastomotic aneurysms: Pathogenic factors, clinical presentations and treatment. A study of 142 cases</article-title><source>Cardiovasc. Surg.</source><year>1999</year><volume>7</volume><fpage>315</fpage><lpage>322</lpage><pub-id pub-id-type="doi">10.1016/S0967-2109(98)00161-6</pub-id><pub-id pub-id-type="pmid">10386749</pub-id></element-citation></ref><ref id="B28-jcm-13-04323"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Markovi&#263;</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Davidovi&#263;</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Kosti&#263;</surname><given-names>D.M.</given-names></name><name name-style="western"><surname>Maksimovi&#263;</surname><given-names>&#381;.V.</given-names></name><name name-style="western"><surname>&#268;inara</surname><given-names>I.S.</given-names></name><name name-style="western"><surname>Cvetkovi&#263;</surname><given-names>S.D.</given-names></name><name name-style="western"><surname>Markovi&#263;</surname><given-names>M.D.</given-names></name><name name-style="western"><surname>Draga&#353;</surname><given-names>M.V.</given-names></name></person-group><article-title>Anastomotic pseudoaneurysms</article-title><source>Srpski Arhiv za Celokupno Lekarstvo</source><year>2006</year><volume>134</volume><fpage>114</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.2298/SARH0604114M</pub-id><pub-id pub-id-type="pmid">16915751</pub-id></element-citation></ref><ref id="B29-jcm-13-04323"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pogorzelski</surname><given-names>R.</given-names></name><name name-style="western"><surname>Fiszer</surname><given-names>P.</given-names></name><name name-style="western"><surname>Toutounchi</surname><given-names>S.</given-names></name><name name-style="western"><surname>Krajewska</surname><given-names>E.</given-names></name><name name-style="western"><surname>Szostek</surname><given-names>M.M.</given-names></name><name name-style="western"><surname>Tworus</surname><given-names>R.</given-names></name><name name-style="western"><surname>Jakuczun</surname><given-names>W.</given-names></name><name name-style="western"><surname>Sk&#243;rski</surname><given-names>M.</given-names></name></person-group><article-title>Anastomotic aneurysms&#8212;20-years of experience from one center</article-title><source>Pol. Przegl Chir.</source><year>2013</year><volume>85</volume><fpage>181</fpage><lpage>191</lpage><pub-id pub-id-type="doi">10.2478/pjs-2013-0028</pub-id><pub-id pub-id-type="pmid">23640925</pub-id></element-citation></ref><ref id="B30-jcm-13-04323"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gali&#241;anes</surname><given-names>E.L.</given-names></name><name name-style="western"><surname>Dombrovskiy</surname><given-names>V.Y.</given-names></name><name name-style="western"><surname>Graham</surname><given-names>A.M.</given-names></name><name name-style="western"><surname>Vogel</surname><given-names>T.R.</given-names></name></person-group><article-title>Endovascular versus open repair of popliteal artery aneurysms: Outcomes in the US Medicare population</article-title><source>Vasc. Endovasc. Surg.</source><year>2013</year><volume>47</volume><fpage>267</fpage><lpage>273</lpage><pub-id pub-id-type="doi">10.1177/1538574413475888</pub-id><pub-id pub-id-type="pmid">23393086</pub-id></element-citation></ref><ref id="B31-jcm-13-04323"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Naazie</surname><given-names>I.N.</given-names></name><name name-style="western"><surname>Khan</surname><given-names>M.A.</given-names></name><name name-style="western"><surname>Gupta</surname><given-names>J.D.</given-names></name><name name-style="western"><surname>Patel</surname><given-names>R.</given-names></name><name name-style="western"><surname>AbuRahma</surname><given-names>A.</given-names></name><name name-style="western"><surname>Malas</surname><given-names>M.B.</given-names></name></person-group><article-title>Open Repair Versus Endovascular Repair in the Treatment of Symptomatic Popliteal Artery Aneurysms</article-title><source>Ann. Vasc. Surg.</source><year>2022</year><volume>86</volume><fpage>77</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1016/j.avsg.2022.06.096</pub-id><pub-id pub-id-type="pmid">35870674</pub-id></element-citation></ref><ref id="B32-jcm-13-04323"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Koksoy</surname><given-names>C.</given-names></name><name name-style="western"><surname>Gyedu</surname><given-names>A.</given-names></name><name name-style="western"><surname>Alacayir</surname><given-names>I.</given-names></name><name name-style="western"><surname>Bengisun</surname><given-names>U.</given-names></name><name name-style="western"><surname>Uncu</surname><given-names>H.</given-names></name><name name-style="western"><surname>Anadol</surname><given-names>E.</given-names></name></person-group><article-title>Surgical treatment of peripheral aneurysms in patients with Behcet&#8217;s disease</article-title><source>Eur. J. Vasc. Endovasc. Surg.</source><year>2011</year><volume>42</volume><fpage>525</fpage><lpage>530</lpage><pub-id pub-id-type="doi">10.1016/j.ejvs.2011.05.010</pub-id><pub-id pub-id-type="pmid">21641238</pub-id></element-citation></ref><ref id="B33-jcm-13-04323"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aronow</surname><given-names>W.S.</given-names></name></person-group><article-title>Peripheral arterial disease of the lower extremities</article-title><source>Arch. Med. Sci.</source><year>2012</year><volume>8</volume><fpage>375</fpage><lpage>388</lpage><pub-id pub-id-type="doi">10.5114/aoms.2012.28568</pub-id><pub-id pub-id-type="pmid">22662015</pub-id><pub-id pub-id-type="pmcid">PMC3361053</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="jcm-13-04323-f001" orientation="portrait"><label>Figure 1</label><caption><p>Intraoperative angiography&#8212;true aneurysm of popliteal artery (<bold>a</bold>), pseudoaneurysm of popliteal artery (<bold>b</bold>). Note: (<bold>a</bold>) (red arrow)&#8212;a smooth, rounded expansion of the artery involving the entire circumference of the vessel, indicating that all three layers of the arterial wall (intima, media, and adventitia) are involved. (<bold>b</bold>) (red arrow) an irregular dilation of the artery that is contained by periarterial connective tissue.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g001.jpg"/></fig><fig position="float" id="jcm-13-04323-f002" orientation="portrait"><label>Figure 2</label><caption><p>Computed tomography angiography&#8212;true aneurysm of popliteal artery (<bold>a</bold>), pseudoaneurysm of common femoral artery (<bold>b</bold>). Note: (<bold>a</bold>) (red arrow)&#8212;round, sharply demarcated from the surrounding tissues dilatation with the involvement of the intima, media, and adventitia of the popliteal artery. (<bold>b</bold>) (red arrow)&#8212;poorly demarcated common femoral artery dilations contained by periarterial connective tissue.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g002.jpg"/></fig><fig position="float" id="jcm-13-04323-f003" orientation="portrait"><label>Figure 3</label><caption><p>Freedom from reoperations after 12 months&#8212;overall (<bold>a</bold>), true aneurysm vs. pseudoaneurysm group (<bold>b</bold>) (Statistica<sup>&#174;</sup>, 13.3, StatSoft).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g003.jpg"/></fig><fig position="float" id="jcm-13-04323-f004" orientation="portrait"><label>Figure 4</label><caption><p>Freedom from amputations after 12 months&#8212;overall (<bold>a</bold>), true aneurysm vs. pseudoaneurysm group (<bold>b</bold>) (Statistica<sup>&#174;</sup>, 13.3, StatSoft).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g004.jpg"/></fig><fig position="float" id="jcm-13-04323-f005" orientation="portrait"><label>Figure 5</label><caption><p>Freedom from graft stenosis after 12 months&#8212;overall (<bold>a</bold>), true aneurysm vs. pseudoaneurysm group (<bold>b</bold>) (Statistica<sup>&#174;</sup>, 13.3, StatSoft).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g005.jpg"/></fig><fig position="float" id="jcm-13-04323-f006" orientation="portrait"><label>Figure 6</label><caption><p>Freedom from reoperation-amputation-stenosis (RAS) events after 12 months&#8212;overall (<bold>a</bold>), true aneurysm vs. pseudoaneurysm group (<bold>b</bold>) (Statistica<sup>&#174;</sup>, 13.3, StatSoft). Abbreviations: RAS events&#8212;reoperation-amputation-stenosis events.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g006.jpg"/></fig><fig position="float" id="jcm-13-04323-f007" orientation="portrait"><label>Figure 7</label><caption><p>Overall survival&#8212;overall (<bold>a</bold>), true aneurysm vs. pseudoaneurysm group (<bold>b</bold>) (Statistica<sup>&#174;</sup>, 13.3, StatSoft).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="jcm-13-04323-g007.jpg"/></fig><table-wrap position="float" id="jcm-13-04323-t001" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t001_Table 1</object-id><label>Table 1</label><caption><p>Demographic and clinical patient characteristics by type of the aneurysm.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of the Aneurysm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">True Aneurysm<break/>(n = 71; 64.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm<break/>(n = 39; 35.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (n = 110)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67 (51&#8211;98) IQR 11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">68 (15&#8211;83) IQR 9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">67.5 (15&#8211;98) IQR 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.03</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">65 (91.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 (76.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95 (86.4%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (8.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (23.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (13.6%)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presence of comorbidities </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56 (78.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 (87.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 (81.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 (70.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (69.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">77 (70%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (28.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (59%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43 (39.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (22.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (33.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29 (26.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 (19.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (33.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (24.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 (15.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 (20.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (17.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (12.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (25.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (17.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Heart failure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (18%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (10.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.08</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (5.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Dialysis dependence</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (5.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">History of cigarette smoking (yes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33 (46.48%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (48.72%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52 (47.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Current cigarette smoking (yes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (32.39%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (38.46%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38 (34.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Clinical symptoms (yes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47 (66.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (61.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">71 (64.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Lower limb pain</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (38%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (41%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43 (39.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute limb ischemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 (25.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (7.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (19.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intermittent claudication</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (16.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (12.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (15.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Limb swelling</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (6.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ulcer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (7.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm rupture</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (2.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gangrene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presence of other aneurysms (yes)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 (59.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (38.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">57 (51.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Abdominal aorta aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (21.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (15.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (19.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (21.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (7.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 (16.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (9.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (10.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 (10%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (5.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (5.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common iliac artery aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: COPD&#8212;chronic obstructive pulmonary disease, IQR&#8212;interquartile range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t002" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t002_Table 2</object-id><label>Table 2</label><caption><p>Characteristics of aneurysms in the study population.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of the Aneurysm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">True Aneurysm<break/>(n = 71; 64.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm<break/>(n = 39; 35.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (n = 110)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm localization (artery)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">52 (73.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54 (49.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (23.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36 (92.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">53 (48.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (2.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size (mm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36 IQR 21.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">25 IQR 34.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36 IQR 20 mm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True aneurysm etiology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Idiopathic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51 (81.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51 (46.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (28.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (18.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm etiology</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arterial anastomosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 (94.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37 (38.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8226;&#8195;Aortobifemoral bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (61.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 (21.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8226;&#8195;Femoropopliteal bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (25.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (9.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8226;&#8195;Aortofemoral bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (15.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 (5.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#8226;&#8195;Iliofemoral bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.81%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Injury</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.81%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: IQR&#8212;interquartile range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t003" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t003_Table 3</object-id><label>Table 3</label><caption><p>Intraoperative properties and complications.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of the Aneurysm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">True Aneurysm<break/>(n = 71; 64.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm<break/>(n = 39; 35.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (n = 110)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Duration of procedure (minutes)</td><td align="center" valign="middle" rowspan="1" colspan="1">170 (45&#8211;315) IQR 97.5</td><td align="center" valign="middle" rowspan="1" colspan="1">150 (60&#8211;365) IQR 79</td><td align="center" valign="middle" rowspan="1" colspan="1">165.5 (45&#8211;365) IQR 77.5</td><td align="center" valign="middle" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">39 (54.9%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">34 (87.2%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">73 (66.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">16 (22.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">17 (15.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Surgical bypass</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15 (21.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15 (13.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">&lt;0.001</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (10.3%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">5 (4.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.05</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Intraoperative blood loss</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">&lt;400 mL</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">65 (91.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">38 (97.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">103 (93.7%)</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">&gt;400 mL</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">6 (4.2%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 (5.4%)</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Transfusion of red blood cells (RBC)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">5 (7%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">6 (5.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Transfusion of fresh frozen plasma (FFP)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">2 (1.8%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.05</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">67 (94.37%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">32 (82.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">99 (90%)</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (5.63%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 (18)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 (10%)</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Duration of hospitalization (days)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 (5&#8211;26) IQR 5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">9 (4&#8211;100) IQR 4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 (4&#8211;100) IQR 4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Duration of postoperative hospitalization (days)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (1&#8211;25) IQR 3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">5 (2&#8211;90) IQR 5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (1&#8211;90) IQR 4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Early postoperative complications</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">16 (22.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">9 (23.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">25 (22.7%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Surgical site infection</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (5.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">6 (15.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 (9.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Hematoma</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 (9.8%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 (7.3%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Acute limb ischemia</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">3 (3.2%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">4 (3.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Femoral abscess</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">C.Difficile infection</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0 (0%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Early reoperations</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">8 (13.8%)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">2 (5.7%)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">10 (9.1%)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">0.3</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: C.Difficile&#8212;clostridium difficile, IQR&#8212;interquartile range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t004" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t004_Table 4</object-id><label>Table 4</label><caption><p>Univariate analysis of predictive factors for early postoperative complications after the treatment of lower limb aneurysms using logistic regression.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">n (%)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td colspan="5" align="center" valign="middle" rowspan="1">Pre-operative</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">95 (86.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15 (13.6%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3&#8211;4.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">90 (81.8%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5&#8211;7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">77 (70%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">43 (39.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.2&#8211;7.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.02</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">29 (26.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5&#8211;3.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">27 (24.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.6</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.6&#8211;4.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Dyslipidemia</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">19 (17.3%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Diabetes mellitus</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">19 (17.3%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Heart failure</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">12 (10.9%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5&#8211;6.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">COPD</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">6 (5.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">3.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7&#8211;20</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of cigarette smoking (yes)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">52 (47.3%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.6</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.6&#8211;3.9</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Current cigarette smoking(yes)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">38 (34.5%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.08</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;2.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Aneurysm localization</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">54 (49.1%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2&#8211;1.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">53 (48.2%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.33</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.54&#8211;3.3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td colspan="5" align="center" valign="middle" style="border-top:solid thin" rowspan="1">Intra-operative</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Type of procedure</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">73 (66.4%)</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;2.9</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">17 (15.5%)</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">0.4&#8211;3.6</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Surgical bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 (13.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;2.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 (4.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4&#8211;15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Blood loss</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&gt;400 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7 (6.3%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;20.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&lt;400 mL</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Duration of procedure </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9&#8211;1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: COPD&#8212;chronic obstructive pulmonary disease, OR&#8212;odds ratio, 95% CI&#8212;95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t005" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t005_Table 5</object-id><label>Table 5</label><caption><p>Follow-up data.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Type of the Aneurysm</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">True Aneurysm<break/>(n = 71; 64.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm<break/>(n = 39; 35.5%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Total (n = 110)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Follow-up time (months)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (1&#8211;68) IQR 31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (1&#8211;60) IQR 33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (1&#8211;68) IQR 31 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Late postoperative complications</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18 (25.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (23.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27 (24.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acute limb ischemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14 (19.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (7.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">17 (15.5%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chronic limb ischemia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (4.2%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 (3.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal abscess</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prosthesis infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (1.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Myocardial infarction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Recurrence of pseudoaneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intracerebral hemorrhage</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0 (0.0%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (2.6%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (0.9%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Late reoperations</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (14.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (7.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 (11.8%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mortality</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (1.4%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2 (5.1%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 (2.7%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: IQR&#8212;interquartile range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t006" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t006_Table 6</object-id><label>Table 6</label><caption><p>Univariate analysis of predictive factors for freedom from reoperations using Cox proportional hazards regression model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Freedom from Reoperations (Months)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 14.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2&#8211;1.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7.4 IQR 15</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7.5 IQR 12.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;1.9</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.9 IQR 21.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Current cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 14</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2&#8211;1.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.1 IQR 15</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 13</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.6&#8211;4.6</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 22</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 IQR 14.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7&#8211;3.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.8 IQR 14.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 17</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3&#8211;1.9</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 14</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 IQR 10.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;2.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.2 IQR 15.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Localization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 IQR 11.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7&#8211;3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 20.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.9 IQR 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;17.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 IQR 17</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 IQR 28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6&#8211;4.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 IQR 12.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.06</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8&#8211;5.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 19.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 IQR 22.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.51&#8211;42.56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.17</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HR&#8212;hazard ratio, 95% CI&#8212;95% confidence interval, IQR&#8212;interquartile range.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t007" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t007_Table 7</object-id><label>Table 7</label><caption><p>Univariate analysis of factors with freedom from amputations using Cox proportional hazards regression model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Freedom from Amputations (Months)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9&#8211;1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 29.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.02&#8211;3.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 23.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 17.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.1&#8211;6.5</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15 IQR 36.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Current cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 17.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.1&#8211;11</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 32.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 25</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.1&#8211;8.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">9 IQR 32</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.3</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 31.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">3.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3&#8211;35.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 27</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">13 IQR 27</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 28</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 30.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Localization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 IQR 32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.9 IQR 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;12.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 IQR 37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;32.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 IQR 20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 29.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 IQR 22.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6&#8211;73.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HR&#8212;hazard ratio, 95% CI&#8212;95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t008" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t008_Table 8</object-id><label>Table 8</label><caption><p>Uni- and multivariate analysis of factors with freedom from graft stenosis using Cox proportional hazards regression model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Multivariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Freedom from Graft Stenosis (Months)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 20.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">7.4 IQR 15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">History of cigarette smoking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.5 IQR 12.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.5 IQR 21.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Current cigarette smoking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 13.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;2.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 IQR 22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 20.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;1.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 14.4</td><td align="center" valign="middle" style="border-bottom:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 15.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Localization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5 IQR 11.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8&#8211;14.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.002</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 IQR 27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04&#8211;0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.03&#8211;1.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.5 IQR 15.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8 IQR 14.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 IQR 36</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8&#8211;6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 IQR 12.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.4&#8211;10.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.001</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 18.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 IQR 22.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;4.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HR&#8212;hazard ratio, 95% CI&#8212;95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t009" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t009_Table 9</object-id><label>Table 9</label><caption><p>Uni- and multivariate analysis of factors with freedom from RAS events using Cox proportional hazards regression model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th><th colspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Multivariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Freedom from RAS Events (Months)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.8 IQR 15</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.25&#8211;1.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7.4 IQR 22</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.9</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.1 IQR 14</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5&#8211;2.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.4 IQR 21.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Current cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.5</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.5 IQR 16</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.4&#8211;1.7</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8.1 IQR 14.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">9 IQR 13</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.5&#8211;2.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 IQR 22</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">7 IQR 15</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.7&#8211;2.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">9 IQR 14.4</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.6</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 14</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3&#8211;1.9</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">8 IQR 14</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">0.8</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 IQR 11</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4&#8211;2.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8 IQR 15.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Localization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 IQR 12.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;4.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.06</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;0.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.02&#8211;0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.005</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9.9 IQR 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;13.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 IQR 13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.2 IQR 16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;1.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4 IQR 28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7&#8211;3.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">6 IQR 13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8&#8211;4.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.9 IQR 13.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3 IQR 22.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04&#8211;2.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HR&#8212;hazard ratio, 95% CI&#8212;95% confidence interval.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="jcm-13-04323-t010" orientation="portrait"><object-id pub-id-type="pii">jcm-13-04323-t010_Table 10</object-id><label>Table 10</label><caption><p>Univariate analysis of factors with overall survival using Cox proportional hazards regression model.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Univariable Analysis</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Variable</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Survival Time (Months)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">HR</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">95% CI</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" rowspan="1" colspan="1">1&#8211;1.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.01</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Gender</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 31</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.3</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.03&#8211;3.7</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 25</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">History of cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 18</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15.5 IQR 37</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Current cigarette smoking</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">10 IQR 19</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">13.5 IQR 34</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Presence of comorbidities</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Arterial hypertension</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" colspan="1">0.2</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 29</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.02&#8211;2.5</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">15 IQR 32</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Generalized atherosclerosis</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin" colspan="1">0.8</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 33</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.76</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.07&#8211;8.4</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">11 IQR 31</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Coronary artery disease</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">13 IQR 27</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">1.2</td><td align="center" valign="middle" style="border-top:solid thin" rowspan="1" colspan="1">0.1&#8211;13.1</td></tr><tr><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 33</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">History of myocardial infarction</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 24</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;20.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 IQR 30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Localization</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Popliteal artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 IQR 27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.07&#8211;9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Common femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 IQR 32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;19.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Superficial femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26.5 IQR 15.5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Deep femoral artery</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysm size</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">True aneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 33</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pseudoaneurysm</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13 IQR 28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.3&#8211;33.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Type of the procedure</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 IQR 23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.1&#8211;11.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endovascular treatment</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">29 IQR 37</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.2&#8211;21.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15 IQR 32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Aneurysmectomy with bypass</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11 IQR 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Graft material</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Synthetic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">11.5 IQR 31.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Patient&#8217;s vein</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5.5 IQR 22.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Abbreviations: HR&#8212;hazard ratio, 95% CI&#8212;95% confidence interval.</p></fn></table-wrap-foot></table-wrap></floats-group></article></pmc-articleset>